Copyright © 2016
Aridis Pharmaceuticals, Inc.
5941 Optical Court, San Jose, CA 95138
Clinical Advisory Board
Jean Chastre, M.D.
Dr. Chastre, Consulting Professor in the Medical ICU and former director of the same ICU at Institut de Cardiologie, Groupe Hospitalier Pitié-
Marin Kollef, M.D.
Dr. Kollef is the director of the medical intensive care unit and respiratory care services at Barnes-
Bruno Francois, M.D.
Dr. Francois, a specialist in intensive care medicine and anesthesiology, heads the Limoges Clinical Investigation Center with a specific focus on infectious diseases in critically ill patients at the University Hospital of Limoges, France. He has participated in several advisory boards for Sepsis and VAP multinational trials, independent clinical evaluation committees and adjudication committees. He is also the author of multiple publications and a reviewer for medical journals focused on infectious disease in the ICU. He is currently investigating the role of bacterial resistance mechanisms and integrons during Sepsis with the Marie-
Michael Niederman, M.D.
Dr. Niederman is Professor of Medicine and Vice-
Richard B. Moss, M.D.
Dr. Moss is professor of Pediatrics at Stanford University School of medicine and chief, pediatric pulmonology and allergy with over 150 scientific publications. He is the chair of the protocol review committee for the Cystic Fibrosis Therapeutics Development Network (TDN). Dr. Moss’s honors include The Best Doctors in America, America’s Top Pediatricians -
Alan H Cohen, M.D., FAAP, FCCP
Dr Cohen is a board certified Pediatric Pulmonologist and currently the Vice President, Clinical Development and Medical Affairs at Intermune. He also holds an appointment as adjunct clinical faculty at Stanford University School of Medicine – in the Dept of Pediatric Pulmonology and Allergy. He is the author of over 100 peer reviewed articles, abstracts, platform presentations and book chapters in his areas of interest and expertise, including Cystic Fibrosis, Lung Transplantation, Infectious Disease and respiratory pathogens. He was formerly the Senior Director of Medical Affairs at Medimmune. He has held faculty appointments in a number of academic centers including the Johns Hopkins School of Medicine, Morehouse School of Medicine, Washington University School of Medicine, as well as the University of Colorado / National Jewish Center for Immunology and Respiratory Diseases.
Breakthrough Therapies for
Antibiotic Resistant Infections